Active substance(s): CAMPHOR RACEMIC / MENTHOL / PINE NEEDLE OIL
NAME OF THE MEDICINAL PRODUCT
QUALITATIVE AND QUANTITATIVE COMPOSITION
Siberian Pine Needle Oil
Nasal stick; for nasal use.
The relief of nasal congestion associated with allergic and infectious upper
respiratory tract disorders.
Posology and method of administration
Adults and children over 6 years: Vicks Inhaler is used by inserting the inhaler
into each nostril, holding the other nostril closed and inhaling deeply.
It can be used as frequently as needed.
Children under 6 years: Not recommended.
Use in patients hypersensitive to any of the ingredients.
Special warnings and precautions for use
If symptoms persist consult your doctor.
Interaction with other medicinal products and other forms of interaction
Pregnancy and lactation
No effects during pregnancy are anticipated, since systematic exposure to
Menthol, Camphor and Siberian Pine Needle Oil is negligible. Vicks Inhaler
can be used during pregnancy.
Effects on ability to drive and use machines
In general no serious or severe side effects are expected with this product.
Very rarely cases of nasal discomfort have been reported.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the medicinal
product. Healthcare professionals are asked to report any suspected adverse reactions
via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
Symptoms: No clinically significant cases of overdose have been reported.
Management of an overdose: None
Menthol, Camphor and Siberian Pine Needle Oil act locally in the respiratory
The product exerts its action locally; little or no absorption is expected to
Preclinical safety data
List of excipients
Special precautions for storage
Do not store above 25°C.
Nature and contents of container
A cellulose wick soaked in medication enclosed in a plastic holder with a
Special precautions for disposal
MARKETING AUTHORISATION HOLDER
Procter & Gamble (Health & Beauty Care) Limited
MARKETING AUTHORISATION NUMBER
DATE OF FIRST AUTHORISATION/RENEWAL OF THE
DATE OF REVISION OF THE TEXT
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.